Cargando…
Topical human recombinant nerve growth factor for stage 1 Neurotrophic Keratitis: Retrospective case series of cenegermin treatment
PURPOSE: To report on the management and effectiveness of treating patients with stage I Neurotrophic Keratitis using an 8-week course of topical recombinant human nerve growth factor (rhNGF, cenegermin). OBSERVATIONS: In this retrospective case series, punctate epithelial erosions (PEE), best corre...
Autores principales: | Epitropoulos, Alice T., Weiss, Jamie L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350864/ https://www.ncbi.nlm.nih.gov/pubmed/35938145 http://dx.doi.org/10.1016/j.ajoc.2022.101649 |
Ejemplares similares
-
Update On Cenegermin Eye Drops In The Treatment Of Neurotrophic Keratitis
por: Sheha, Hosam, et al.
Publicado: (2019) -
Neurotrophic Keratopathy Treated with Topical Recombinant Human Nerve Growth Factor (Cenegermin): Case Series Study with Long-Term Follow-Up
por: García-Delpech, Salvador, et al.
Publicado: (2022) -
A Novel Treatment for Neurotrophic Corneal Ulcer Using Topical Cenegermin (OXERVATE™) Containing Recombinant Human Nerve Growth Factor
por: Ahuja, Abhimanyu S, et al.
Publicado: (2020) -
Role of Topical Cenegermin in Management of a Cornea Transplant in a Functionally Monocular Patient with Neurotrophic Keratitis and Facial Nerve Palsy: A Case Report
por: Pocobelli, Augusto, et al.
Publicado: (2020) -
Neurotrophic keratopathy: Clinical presentation and effects of cenegermin
por: Bu, Julia Bing, et al.
Publicado: (2022)